Michelson Medical Research Foundation’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Michelson Medical Research Foundation’s Portfolio VEA Stock Details VEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Hold	158,160	–	–	10.41%	2
2026 Q1	$10.1M	Hold	158,160	–	–	10.29%	3
2025 Q4	$9.88M	Hold	158,160	–	–	9.9%	4
2025 Q3	$9.48M	Hold	158,160	–	–	8.24%	5
2025 Q2	$9.02M	Hold	158,160	–	–	8.65%	5
2025 Q1	$8.04M	Hold	158,160	–	–	6.73%	7
2024 Q4	$7.56M	Sell	158,160 -203,000	-56%	-$10.2M	6.34%	5
2024 Q3	$19.1M	Hold	361,160	–	–	13.45%	1
2024 Q2	$17.8M	Hold	361,160	–	–	15.35%	1
2024 Q1	$18.1M	Hold	361,160	–	–	10.98%	2
2023 Q4	$7.3M	Hold	361,160	–	–	4.81%	9
2023 Q3	$15.8M	Buy	361,160 +55,285	+18%	+$2.53M	10.66%	2
2023 Q2	$14.1M	Hold	305,875	–	–	10.05%	2
2023 Q1	$13.8M	Hold	305,875	–	–	10.83%	2
2022 Q4	$12.8M	Buy	+305,875	New	+$12.4M	8.31%	6

Other funds holding VEA

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Betterment LLC New York $59.1B AUM 18.41% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Wealthfront Advisers Palo Alto, California $52B AUM 24.53% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Michelson Medical Research Foundation's VEA Position: Q2 2026 in Review

Michelson Medical Research Foundation held its Vanguard FTSE Developed Markets ETF (VEA) position steady in Q2 2026 at 158,160 shares worth $11.3M. The position accounts for 10.41% of the portfolio, ranked #2.

Michelson Medical Research Foundation first reported a position in VEA in Q4 2022 and has held it in 15 quarters since. The position peaked at $19.1M in Q3 2024. 2,984 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

Michelson Medical Research Foundation held 158,160 shares of Vanguard FTSE Developed Markets ETF worth $11.3M as of Q2 2026.
Michelson Medical Research Foundation left its Vanguard FTSE Developed Markets ETF share count unchanged in Q2 2026.
Vanguard FTSE Developed Markets ETF made up 10.41% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #2 holding.
Michelson Medical Research Foundation first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2022 and has held it in 15 quarters since.
Michelson Medical Research Foundation's Vanguard FTSE Developed Markets ETF position peaked at $19.1M in Q3 2024.
2,984 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.